logo

COURSE STRUCTURE

RECENT ANNOUNCEMENTS

No announcements have been made for this course

General

Skill level: All levels
Release date: October 14, 2022
Expiration date: October 14, 2023

Languages

English

Description

DISCLOSURE OF CONFLICTS OF INTEREST

Your CE Source ensures balance, independence, objectivity, and scientific rigor in all our educational programs. In accordance with this policy, Your CE Source identifies conflicts of interest with its instructors, content managers, and other individuals who are in a position to control the content of an activity. Conflicts are resolved by Your CE Source to ensure that all scientific research referred to, reported, or used in a continuing education activity conforms to the generally accepted standards of experimental design, data collection, and analysis. Your CE Source is committed to providing its learners with high-quality activities that promote improvements or quality in healthcare and not the business interest of a commercial interest.

The faculty reported the following financial relationships with commercial interests whose products or services may be mentioned in this activity

 

Name of Faculty

Reported Financial Relationship

Akilesh Palanisamy, MD

No financial relationships to disclose.

   

Apple Bodemer, MD

No financial relationships to disclose.

   

Brindley Brooks

No financial relationships to disclose.

   

Cassandra Quave, PhD

Grants/Research Support: National Institutes of Health

Consulting Fees: CEO consulting small business - CLQ Botanicals LLC

Speakers Bureau: Represented by BrightSight Speakers

Other: CEO/CSO PhytoTEK LLC

   

DiAnne Davis, MD FAAD

No financial relationships to disclose.

   

Hadar Lev-Tov, MD MAS

Ownership Interest / Stock Holder: LearnSkin

   

Iltefat Hamzavi, MD

Grant from Estee Lauder
Investigator Clinuvel
Investigator Incyte, Pfizer, Avita, ITN,Ferndale Labs
Consultant Pfizer, Abbvie, Novartis, Aclaris

   

Jason Ezra Hawkes, MD MS FAAD

Consulting Fees: AbbVie, Arcutis, LEO, Lilly, Novartis, Sanofi, UCB, VisualDx

Ownership Interest / Stock Holder: Regeneron Pharmaceuticals (Spouse)

Royalty: UpToDate

Honorarium: National Psoriasis Foundation

Employee: Regeneron Pharmaceuticals (Spouse)

   

Jessica Maloh, ND

Consulting Fees: Codex Beauty (Consultant)

   

Joseph Alban, DAc LAc

No financial relationships to disclose.

   

Kathleen Farah, MD, FAAFP

No financial relationships to disclose.

   

Keira Barr, MD

No financial relationships to disclose.

   

Lakshi Alderdge, MSN RN ANP-BC

Consulting Fees: AbbVie, Sanofi, Regeneron, Lilly, Sun Pharma, UBC, Janssen, Bristol Myers Squibb, Dermavant, Arcutis, Incyte

Speakers Bureau: AbbVie, Sanofi, Regeneron, Lilly, Sun Pharma, UBC, Janssen, Sun Pharma

   

Lawrence Eichenfield, MD

Consultant or investigator, or on a data safety monitoring board for: Abbvie, Almirall, Asana, Cutanea, Dermavant, Dermira, Forte Biosciences, Galderma Laboratories, Glenmark, Incyte, Leo Pharma, Lilly, Matrisys, Otsuka, Novartis, Otsuka, Pfizer, Regeneron, Sanofi Genzyme, Ortho Dermatology

Royalty: UptoDate, Xeroderma Pigmentosa, Elsevier, Neonatal Dermatology

   

Mark Cannon, DDS

Consulting Fees: Unpaid advisor to Probiora, StellaLife and Xlear

   

Michael Traub, ND, DHANP, FABNO

No financial relationships to disclose.

Neal Bhatia, MD

Grants/Research Support: Abbvie, Aclaris, Almirall, Biofrontera, BMS, BiopharmX, Dermira, Encore, EPI Health, Ferndale, Foamix, Galderma, Intraderm, ISDIN, J&J, LaRoche-Posay, Leo, Lilly, Mayne, Menlo, Novartis, Ortho, Pfizer, Pierre-Fabre, Regeneron, Sanofi, SkinFix, Soligenix, SunPharma, Vidac, and Vyome

Consulting Fees: Abbvie, Aclaris, Almirall, Biofrontera, BMS, BiopharmX, Dermira, Encore, EPI Health, Ferndale, Foamix, Galderma, Intraderm, ISDIN, J&J, LaRoche-Posay, Leo, Lilly, Mayne, Menlo, Novartis, Ortho, Pfizer, Pierre-Fabre, Regeneron, Sanofi, SkinFix, Soligenix, SunPharma, Vidac, and Vyome

   

Peter Lio, MD

Grants/Research Support: Investigator - AO Biome, AbbVie, Regeneron/Sanofi GenzymeConsulting Fees: Advisory Board - Almirall, ASLAN, UCB, Dermavant, Regeneron/Sanofi Genzyme, Pfizer, LEO, AbbVie, Eli Lilly, Micreos, L’Oreal, Pierre-Fabre, Johnson & Johnson, Level Ex, Unilever, Menlo Therapeutics, Theraplex, IntraDerm, Exeltis, AOBiome, Realm Therapeutics, Altus Labs, Galderma, Verrica, Arbonne, Amyris, Bodewell, Burt’s Bees, My-Or Diagnostics, and Kimberly-Clark

Speakers Bureau: Speaker - Pfizer, Regeneron/Sanofi Genzyme, Galderma, Lilly, LEOOwnership Interest / Stock Holder: Stock options: Micreos, Altus Labs Royalty: Patent holder/Royalties - Theraplex AIM OTC moisturizer

Other: Board Member - National Eczema Association

   

Pushpa Soundararajan, RD MBA RDN LDN AP CYI

No financial relationships to disclose.

   

Raja Sivamani, MD MS AP

Grants/Research Support: Regeneron, Abbvie, Incyte, Microbiome Labs, Almond Board, Mango Board, Soy Institute, Burts BeesConsulting Fees: Regeneron, Sun Pharma, Novozymes, Abbvie, Leo Pharma, Burts BeesSpeakers Bureau: Almond BoardOwnership Interest / Stock Holder: LearnHealth - Spouse

Advisory Board: LearnHealth, Arbonne

   

Robert Lustig, MD

Grants/ Research Support: NIDDK (Crohn's Disease)

Consulting Fees: Simplex Health, Kalin Health, Myka Bio, ReadOut Health

Ownership Interest / Stock Holder: BioLumen, Inc.

Royalty: Fat Chance (book), 2013

   

Sandra Chiu, LAc MSTCM

No financial relationships to disclose.

   
Sheila Farhang, MD No financial relationships to disclose.
   

Steven Daveluy, MD 

Grants/Research Support: Abbvie

Consulting Fees (e.g. Advisory Board): Abbvie

Speakers Bureau: Abbvie

   

Steven Gurgevich, PhD

Ownership Interest / Stock Holder: President of Behavioral Medicine, Ltd.

 

The content managers reported the following financial relationships with commercial interests whose products or services may be mentioned in this activity:

 

Name of Content Manager

Reported Financial Relationship

Venita Sivamani

LearnHealth Inc. Stockholder

Your CE Source Content Manager

No financial relationships to disclose.

 
CREDIT DESIGNATION
Your CE Source designates this live activity for a maximum of 15.5 AMA PRA Category 1 Credits™. Physicians should claim the credit commensurate with the extent of their participation in the activity. 
 
FOR NURSES
Your CE Source is a provider of continuing nursing education by the California Board of Registered Nursing, Provider #CEP 16031 for 16 contact hours. Nurses should claim the credit commensurate with the extent of their participation in the activity.
 
FOR NATUROPATHIC DOCTORS
The Integrative Dermatology Symposium is approved for 13.5 General and 2 Pharmacology (Total 15.5 CE) credit(s) of continuing education credits by the American Association of Naturopathic Physicians. 
 
FOR ACUPUNCTURISTS AND ORIENTAL MEDICINE PRACTITIONERS
The Integrative Dermatology Symposium is approved by the National Certification Commission for Acupuncture and Oriental Medicine for 16 PDA Points. NCCAOM® PDA Points Provider #9093.
 
CALIFORNIA ACUPUNCTURE BOARD
IDS 2022 (LearnHealth Inc.) is approved by the California Acupuncture Board, Provider Number 1658, for 15 hours of Category 1 continuing education. 
 
FOR AYURVEDA PRACTITIONERS 
The Integrative Dermatology Symposium has been approved for 0.5 TIA and 15 TIW PACE Credits by the National Ayurvedic Medical Association (NAMA). A certificate of completion for this course will be given to all that participate in the 2022 Integrative Dermatology Symposium after completing an evaluation form.
 
FOR ADVANCED PERSONALIZED NUTRITION PRACTITIONERS
The Board for Certification of Nutrition Specialists℠, the certifying arm of the American Nutrition Association® (ANA®), designates this activity for a maximum of 3.25 continuing education credits for the Certified Nutrition Specialist®.

 

DISCLAIMER

The content and views presented in this educational activity are those of the speakers and do not necessarily reflect those of Your CE Source and LearnHealth Inc. The speakers have disclosed if there is any discussion of published and/or investigational uses of agents that are not indicated by the FDA in their presentations. Before prescribing any medicine, primary references and full prescribing information should be consulted. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. The information presented in this activity is not meant to serve as a guideline for patient management.

CONTACT INFORMATION

Questions? Contact LearnSkin support.

Thank you for joining us and we hope to see you in the next activity!

 
 
  Share